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Windows to the young brain
T

here have been incredible strides in imaging
technology over the past 40 years. Where
scientists were once blind to the structure,
chemistry and function of the living brain, they
are now able to extract detailed information using
structural, chemical and functional magnetic
resonance imaging.
From these methods, new understanding of the
precursors and the bases of psychiatric disorders in
the brain have emerged that one day may lead to
more effective therapies for numerous disorders.
Using these methods effectively is a challenge
facing a team of psychiatrists from Wayne State’s
divisions of Child and Adolescent Psychiatry and
Brain Research and Imaging Neuroscience. Drs.
David Rosenberg, Jeffrey Stanley and Vaibhav
Diwadkar have joined forces to try to understand
the vulnerability for, and the bases of, psychiatric
diseases such as attention deficit hyperactivity
disorder, obsessive compulsive disorder and more in
children and adolescents.

Brain tracking
According to the National Institutes of Mental
Health (NIMH), attention deficit hyperactivity
disorder (ADHD) is one of the most common
childhood illnesses, affecting 3 percent to 9
percent of children, and accounting for 30 percent
to 40 percent of child referrals to mental health
services. In addition, the condition can persist into
adulthood in nearly 60 percent of cases, affecting 4
percent of adults.
One study at WSU using brain imaging
technologies and other forms of testing will track
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“Initial findings at Wayne State
University have shown that
glutamate plays a key role in
OCD, Glutamate is the brain’s light
switch that helps turn serotonin
and other chemicals off and on.
Our research has shown that glutamate abnormalities in OCD have
significant treatment implications.
This new study will further our
research by combining imaging
and genetics, something never
assessed in OCD patients.”

— Dr. David Rosenberg

the development of ADHD in the brains of children
and teens.
“The primary aim is to track at what age and
where in the brain developmental differences start
to occur in ADHD compared to the developmental
course of healthy individuals,” said Jeffrey Stanley,
Ph.D., associate professor of psychiatry and

N E W

S C I E N C E

behavioral neurosciences, co-director of the Division
of Brain Research and Imaging Neuroscience,
and program director and graduate officer of the
Translational Neuroscience Program in the School
of Medicine.
“The cause and progression of this illness is
poorly understood biochemically, anatomically
and functionally,” Stanley said. “The goal of this
study, funded by the NIMH, is to map out the
developmental course of ADHD using neuroimaging
biomarkers and to identify at what age and where
in the brain changes are occurring in ADHD that
deviate from the normal development course of
healthy children. Certain brain areas or networks
mature earlier than others, and we anticipate
seeing neuroimaging alterations occurring in later
maturing areas, such as the prefrontal cortex, that
were potentially influenced by maldeveloped earlier
brain areas.”
“By conducting functional imaging studies
in parallel to studies of structure and chemistry,
we will also be able to assess the impact of
altered neurodevelopment on the functions of
developing networks in the brain - networks that
are important for basic and lifelong behaviors such
as attention, memory and emotion,” said Vaibhav
Diwadkar, Ph.D., assistant professor of psychiatry
and behavioral neurosciences and co-director
of the Division of Brain Research and Imaging
Neuroscience.
The age that brain networks change in children
with ADHD or how those early impaired networks
influence other networks within the brain is
unknown. Early identification of affected networks
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Windows to the young brain continued

Combining imaging and genetics
Wayne State is leading the first-ever combined
imaging and genetics research study on obsessivecompulsive disorder (OCD) in child psychiatry,
funded by the National Institute of Mental Health
at the National Institutes of Health.
The project, Brain Chemistry and Genetics in
Pediatric OCD, led by WSU, with collaborative
partners at the University of Michigan and the
University of Toronto/The Hospital for Sick
Children (SickKids), is focused on OCD, a severe,
prevalent and chronically disabling disease. OCD
affects approximately 1 percent to 3 percent of the
population nationwide and about 50 percent of all
OCD cases begin in childhood and adolescence.
“Initial findings at Wayne State University
have shown that glutamate plays a key role in
OCD,” said David Rosenberg, M.D., the Miriam L.
Hamburger Endowed Chair of Child Psychiatry and
professor of psychiatry in the School of Medicine
at Wayne State University and the principal
investigator of the project. “Glutamate is the brain’s
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light switch that helps turn serotonin and other
chemicals off and on. Our research has shown that
glutamate abnormalities in OCD have significant
treatment implications. This new study will further
our research by combining imaging and genetics,
something never assessed in OCD patients.”
By performing critical imaging and genetic
tests of glutamate genes in 200 OCD and 200
healthy control patients, this group of scientists
aims to examine glutamate changes in brain
regions implicated in OCD, and to combine this
information with a detailed exploration of variants
within genes influencing glutamate transmission.
Brain processes visualized using magnetic
resonance imaging are thought to be closer to the
action of genes compared with complex behavioral
phenomena like OCD. By combining the two
powerful techniques of neuroimaging and genetics,
Rosenberg and his collaborators hope to speed the
discovery of risk genes.
Results will have significant scientific
implications as well as key “translational”
importance in bringing research from the bench
to the bedside with clinical ramifications. By
combining unique clinical assessment, magnetic
resonance imaging and genetics expertise, the team
of researchers will investigate biological, genetic
and behavioral variables that may one day lead to a
better understanding of pediatric OCD, and in turn,
the development of new diagnostic and
treatment approaches.

About Dr. Vaibhav Diwadkar:
Dr. Diwadkar received a B.S. in psychology and
Computer Science from Coe College, Iowa. He
received a Ph.D. in cognitive science and psychology
from Vanderbilt University. He joined Wayne State
University in 2005.

About Dr. David Rosenberg:
Dr. Rosenberg received a B.S. in biomedical science
and a M.D. in general psychiatry from the University
of Michigan. He completed his general and child
psychiatry residency at the University of Pittsburgh
and post-doctoral research fellowship at the National
Institute of Mental Health. He joined Wayne State
University in 1996.
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and charting changes, Stanley said, is critical for
researchers to gain a greater understanding of the
development and progression of the condition, and
in developing more-effective therapies.
“The early identification of impaired networks
and charting temporally impaired networks in
ADHD is critical in gaining a greater understanding
of the development and progression of ADHD,”
Stanley said. “This will result in developing
better targeted and age-appropriate cognitive and
behavioral therapy for ADHD.”
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About Dr. Jeffrey Stanley:
Dr. Stanley received a B.S. and M.S. in physics from
the University of Waterloo, and a Ph.D. in medical
biophysics from the University of Western Ontario. He
joined Wayne State University in 2004.

For more information visit: http://brain.wayne.edu
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